The UK's fertility regulator, Human Fertilisation and Embryology Authority (HFEA) gave the go-ahead for the controversial experiment to the Francis Crick Institute in London to provide better understanding of the reasons behind miscarriages.
"Miscarriage and infertility are extremely common but they are not very well understood. We believe that this research could improve our understanding of the very earliest stages of human life," Kathy Niakan, lead scientist of the team, told reporters at a briefing here.
Niakan, who has spent a decade researching human development and had applied for the license to HFEA, wants to understand the first seven days of pregnancy when a fertilised egg moves to a structure called a blastocyst, containing 200-300 cells.
Out of every 100 fertilised eggs, fewer than 50 reach the early blastocyst stage, 25 implant into the womb and only 13 develop beyond three months.
Niakan's experiment will take place in these early days after fertilisation to understand how a human embryo develops.
"I am delighted that the HFEA has approved Niakan's application. Dr Niakan's proposed research is important for understanding how a healthy human embryo develops and will enhance our understanding of IVF success rates, by looking at the very earliest stage of human development - one to seven days," said Paul Nurse, director of the institute.
The team at Francis Crick are already in talks with fertility clinics across the UK to use their spare embryos for research and the experiments can start by next month.
"Our Licence Committee has approved an application from Dr Kathy Niakan of the Francis Crick Institute to renew her laboratory's research licence to include gene editing of embryos," a spokesperson for the HFEA said.
This marks only the second time such an experiment will take place in the world, the first was announced in April last year by scientists in China who carried out gene editing in human embryos to correct a gene that causes a blood disorder.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
